1225O - A Randomized Phase 2 Study of Erlotinib Plus Pemetrexed vs Erlotinib or Pemetrexed Alone as Second-Line Treatment for Never-Smoker Patients with Non-Squamous Advanced Non-Small Cell Lung Cancer (NSCLC)
| Autor: | Lee, D.H., Lee, J.S., Kim, S.W., Rodrigues Pereira, J., Han, B., Song, X.Q., Wang, J., Kim, H.-K., Sahoo, T.P., Digumarti, R., Wang, X., Altug, S., Orlando, M. |
|---|---|
| Zdroj: | In Annals of Oncology September 2012 23 Supplement 9:ix400-ix400 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|